There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small cell lung cancer is often categorized in one of two stages: limited or ...

If you or a loved one has lung cancer, you may be interested in learning more about medicines used to treat it. One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Doru Paul, MD, ...

Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...

The FDA has approved zidesamtinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.Zidesamtinib (Jideytro, GSK) is designed to provide highly selective coverage ...

A diagnosis of non-small cell lung cancer (NSCLC) can significantly affect emotional health, leading to mental health challenges such as depression, anxiety, and distress. Comprehensive mental health ...

RETRACTED: Randomized trial of relevance of time-of-day of immunochemotherapy for progression-free and overall survival in patients with non-small cell lung cancer. Data are n (%). This is an ASCO ...

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...